HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tobias Hahn Selected Research

2,5,7,8- tetramethyl- 2R- (4R,8R,12- trimethyltridecyl)chroman- 6- yloxy acetic acid

3/2013α-TEA as a stimulator of tumor autophagy and enhancer of antigen cross-presentation.
7/2012The vitamin E analogue α-TEA stimulates tumor autophagy and enhances antigen cross-presentation.
11/2011The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
6/2009Orally active alpha-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer.
10/2006Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tobias Hahn Research Topics

Disease

17Neoplasms (Cancer)
03/2016 - 01/2005
7Neoplasm Metastasis (Metastasis)
03/2013 - 05/2006
7Breast Neoplasms (Breast Cancer)
11/2011 - 01/2005
1Communicable Diseases (Infectious Diseases)
01/2016
1Lung Neoplasms (Lung Cancer)
07/2012
1Melanoma (Melanoma, Malignant)
04/2012
1Ovarian Neoplasms (Ovarian Cancer)
04/2012
1Cardiotoxicity
11/2011
1Drug-Related Side Effects and Adverse Reactions
06/2009
1Carcinoma (Carcinomatosis)
06/2009
1Carcinogenesis
06/2009
1Adenoma (Adenomas)
09/2007
1Atrophy
01/2007
1Cleft Palate (Palate, Cleft)
01/2007

Drug/Important Bio-Agent (IBA)

8TeaIBA
03/2016 - 10/2006
7Vitamin EFDA LinkGeneric
03/2013 - 02/2006
5AntigensIBA
03/2013 - 01/2005
52,5,7,8- tetramethyl- 2R- (4R,8R,12- trimethyltridecyl)chroman- 6- yloxy acetic acidIBA
03/2013 - 10/2006
4VaccinesIBA
01/2016 - 02/2006
3Ether (Diethyl Ether)IBA
04/2012 - 01/2011
3Succinic Acid (Succinate)IBA
10/2006 - 01/2005
2Tocopherols (Tocopherol)IBA
03/2013 - 01/2011
2EsterasesIBA
03/2013 - 10/2006
2CytokinesIBA
04/2012 - 06/2009
2alpha-TocopherolFDA Link
11/2011 - 10/2006
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2007 - 05/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2006 - 01/2005
1Recombinant ProteinsIBA
01/2016
1Neoplasm Antigens (Tumor Antigens)IBA
07/2012
1Acetic Acid (Vinegar)FDA LinkGeneric
04/2012
1Pharmaceutical PreparationsIBA
04/2012
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2012
1Therapeutic UsesIBA
04/2012
1LigandsIBA
11/2011
1Trastuzumab (Herceptin)FDA Link
11/2011
1Biomarkers (Surrogate Marker)IBA
11/2011
1InterferonsIBA
01/2011
1AcidsIBA
01/2011
1Phosphotransferases (Kinase)IBA
06/2009
1Transforming Growth Factor beta (TGF-beta)IBA
06/2009
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
06/2009
1OligodeoxyribonucleotidesIBA
09/2007
1Peptides (Polypeptides)IBA
09/2007
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2006
1Celecoxib (Celebrex)FDA Link
05/2006
1Interleukin-4 (Interleukin 4)IBA
05/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2006

Therapy/Procedure

6Therapeutics
07/2012 - 05/2006
4Immunotherapy
04/2012 - 01/2005
1Drug Therapy (Chemotherapy)
11/2011
1Treatment Delay
06/2009
1Maxillary Osteotomy
01/2007